Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127963311 | 12796331 | 1 | I | 20150917 | 20150818 | 20160929 | 20160929 | EXP | US-INCYTE CORPORATION-2015IN004103 | INCYTE | 62.46 | YR | F | Y | 84.82000 | KG | 20160929 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127963311 | 12796331 | 1 | PS | JAKAFI | RUXOLITINIB | 1 | Oral | 20 MG, BID | 0 | 20 | MG | TABLET | BID | ||||||
| 127963311 | 12796331 | 2 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 10 MG, BID | AD6458L | 0 | 10 | MG | TABLET | BID | |||||
| 127963311 | 12796331 | 3 | SS | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | 12.5 MG, PRN | 0 | 12.5 | MG | |||||||||
| 127963311 | 12796331 | 4 | SS | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | UNK UNK, PRN | 0 | |||||||||||
| 127963311 | 12796331 | 5 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Unknown | 1000 MG, QD | N | 0 | 1000 | MG | QD | ||||||
| 127963311 | 12796331 | 6 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Unknown | 325 MG, QD | N | 0 | 325 | MG | QD | ||||||
| 127963311 | 12796331 | 7 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 81 MG | 0 | ||||||||||
| 127963311 | 12796331 | 8 | C | LASIX | FUROSEMIDE | 1 | Unknown | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 127963311 | 12796331 | 9 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 75 MCG, QD | 0 | ||||||||||
| 127963311 | 12796331 | 10 | C | HYDROXYUREA. | HYDROXYUREA | 1 | 1000 MG, QD | 1570000 | MG | 0 | 1000 | MG | QD | ||||||
| 127963311 | 12796331 | 11 | C | LOPERAMIDE HYDROCHLORIDE. | LOPERAMIDE HYDROCHLORIDE | 1 | 2 MG PRN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127963311 | 12796331 | 1 | Polycythaemia vera |
| 127963311 | 12796331 | 3 | Nausea |
| 127963311 | 12796331 | 5 | Iron deficiency |
| 127963311 | 12796331 | 8 | Oedema |
| 127963311 | 12796331 | 9 | Hypothyroidism |
| 127963311 | 12796331 | 11 | Diarrhoea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127963311 | 12796331 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127963311 | 12796331 | Constipation | |
| 127963311 | 12796331 | Diarrhoea | |
| 127963311 | 12796331 | Nausea | |
| 127963311 | 12796331 | Neoplasm malignant | |
| 127963311 | 12796331 | Somnolence | |
| 127963311 | 12796331 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127963311 | 12796331 | 1 | 20150319 | 0 | ||
| 127963311 | 12796331 | 2 | 20150325 | 0 | ||
| 127963311 | 12796331 | 4 | 20130913 | 0 | ||
| 127963311 | 12796331 | 6 | 20150917 | 201511 | 0 | |
| 127963311 | 12796331 | 7 | 20101201 | 0 | ||
| 127963311 | 12796331 | 8 | 2010 | 0 | ||
| 127963311 | 12796331 | 9 | 2010 | 0 | ||
| 127963311 | 12796331 | 10 | 20101201 | 20150319 | 0 | |
| 127963311 | 12796331 | 11 | 20160302 | 0 |